Selected article for: "HSA human serum albumin and human serum albumin"
Author: Rabbani, Gulam; Ahn, Saeyoung Nate
Title: Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19
  • Cord-id: toc496ah
  • Document date: 2021_10_18
    • ID: toc496ah
    Snippet: The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) keeps on destroying normal social integrity worldwide, bringing about extraordinary medical services, cultural and financial interruption. Individuals with diabetes have been demonstrated to be at higher risk of complications and even death when exposed to SARS-CoV-2. Regardless of pandemic scale infection, there is presently limited comprehension on the potential impact of SARS-CoV-2 on individuals with diabetes. Human serum albu
    Document: The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) keeps on destroying normal social integrity worldwide, bringing about extraordinary medical services, cultural and financial interruption. Individuals with diabetes have been demonstrated to be at higher risk of complications and even death when exposed to SARS-CoV-2. Regardless of pandemic scale infection, there is presently limited comprehension on the potential impact of SARS-CoV-2 on individuals with diabetes. Human serum albumin (HSA) is the most abundant circulating plasma protein in human serum and attracted more interest from researchers because most susceptible to non-enzymatic glycation reactions. Albumin down-regulates the expression of ACE2 that is the target receptor of COVID-19. Hypoalbuminemia, coagulopathy, and vascular disease have been connected in COVID-19 and appear to predict outcomes independent of age and morbidity. This review discusses the most recent evidence that the ACE/ACE2 ratio could influence by human serum albumin both the susceptibility of individuals to SARS-CoV-2 infection and the outcome of the COVID-19 disease.

    Search related documents:
    Co phrase search for related documents
    • ace inhibition and activity mrna gene expression: 1
    • ace inhibition and acute respiratory distress syndrome: 1
    • ace inhibition and low effect: 1
    • ace inhibition and lung injury: 1, 2, 3, 4
    • ace inhibitor and active site: 1, 2
    • ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
    • ace inhibitor and adipose tissue: 1
    • ace inhibitor and low effect: 1
    • ace inhibitor and lung alveolar: 1
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • ace inhibitor and lymphocyte count: 1
    • active site and acute respiratory distress syndrome: 1, 2
    • active site and low effect: 1
    • active site and lung injury: 1, 2